Sanofi US News

- Everyone 6 months of age and older recommended for yearly vaccination

Recent survey findings indicate majority of adults fear spreading the flu to family and friends, yet only a third of adults 18 through 64 years of age get a flu shot

- New Prescription Lotion Offers Effective Treatment Option -

-- Breakthrough device design talks patients and caregivers through the injection process --

Technology can provide increased accuracy, efficiency for medical practices

- Four local non-profits receive donations totaling more than $185,000 -

Novel Ideas Sought on How to Better Engage Patients in Their Health

Research collaboration to explore novel target shown in pre-clinical studies to play significant role in type 1 diabetes

- Early shipments of flu vaccine allow health care providers to begin immunization and clinic plans with confidence in vaccine supply -

- Research collaboration with affiliate of Harvard Medical School aims to develop novel therapeutic approaches -

Nearly three-quarters of parents ask caregivers to use approved car safety seats and wash/sanitize their hands, yet fewer than one-fifth ask them to get an adult pertussis vaccine

- No increased risk of cancer found with Lantus® in new European and U.S. observational studies -

- Lixisenatide with basal insulin helped type 2 diabetes patients with uncontrolled HbA1c achieve target blood glucose levels -

- First FDA Cleared Blood Glucose Meter that Connects Directly to iPhone® and iPod touch® -

- Pediatric Data Supplements Prior Phase II and Phase III Studies in Adults -

Birmingham Program to Improve Diabetes Management through Behavioral Economics

- Fox Foundation to sponsor a clinical trial to study Sanofi compound -

- Sanofi to commercialize LeGoo® a highly innovative FDA approved and CE marked gel that provides temporary blood vessel occlusion during surgery -

Fewer Than One in Three Survey Participants Discussed DVT/PE with Healthcare Professional

Dale and Frances Hughes Cancer Center to Receive $500,000 Donation